{
  "ptid_time": "133_S_1031_2008-05-07",
  "img_path": "/data/qiuhui/data/adni/images/133_S_1031/2008-05-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 53,136 mm³, 89.3% above the reference mean. With a Z-score of 2.05 (98.0th percentile), this represents significant enlargement; hippocampal volume measures 4,820 mm³, 32.3% below the reference mean. With a Z-score of -2.96 (0.2th percentile), this represents significant atrophy; whole brain volume measures 881,786 mm³, 9.5% below the reference mean. With a Z-score of -1.20 (11.5th percentile), this represents mild atrophy; entorhinal cortex volume measures 2,173 mm³, 40.8% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,589 mm³, 8.4% below the reference mean. With a Z-score of -0.76 (22.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,506 mm³, 19.1% below the reference mean. With a Z-score of -1.66 (4.9th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 78.6 years. Gender is Female. Education: 18 years. MMSE: 28.0. Laboratory findings: Neutrophils: 77.00 (significant elevated); Monocytes: 3.00 (significant reduced); Basophils: 0.00 (significant reduced); Hematocrit: 50.00 (significant elevated); RBC: 5.50 (significant elevated); WBC: 15.12 (profound elevated); Neutrophils: 11.64 (profound elevated). APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and entorhinal cortex atrophy, which are hallmark features of Alzheimer's disease (AD), along with moderate middle temporal gyrus atrophy. Ventricular enlargement further supports neurodegeneration. However, the MMSE score of 28 is within the normal range, and the absence of APOE4 reduces genetic risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to AD pathology, given the atrophy pattern, but cognitive performance remains largely intact).  \n\n**Confidence:** **Medium** (high confidence in structural AD-like changes, but cognitive scores do not yet meet dementia criteria).  \n\n*Note: Follow-up clinical correlation (e.g., neuropsychological testing for memory deficits) and biomarker confirmation (e.g., CSF Aβ/tau or amyloid PET) would strengthen the diagnosis.*",
  "timestamp": "2025-07-26T15:29:41.156322"
}